Zobrazeno 1 - 10
of 124
pro vyhledávání: '"J. N. van den Anker"'
Autor:
J N van den Anker, Daan J Touw
Publikováno v:
Therapeutic Drug Monitoring, 44(1), 65-74. Lippincott Williams & Wilkins
BACKGROUND: Neonatal infections are associated with high morbidity and mortality rates. Optimal treatment of these infections requires knowledge of neonatal pharmacology and integration of neonatal developmental pharmacokinetics (PKs) of antimicrobia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7b3da23306f112aef52495a5aa0b23
https://pure.eur.nl/en/publications/597d76cb-b031-4f5b-954e-d083df29a1c3
https://pure.eur.nl/en/publications/597d76cb-b031-4f5b-954e-d083df29a1c3
Publikováno v:
Current Pharmaceutical Design. 23:5790-5800
_Introduction:_ Therapeutic drug monitoring (TDM) refers to the interpretation of quantified drug concentrations in strategically timed samples of bodily fluids, with the aim to maximize therapeutic benefit, while minimizing toxicity. In essence, TDM
Autor:
J. N. van den Anker, Helle Holst, Inger Merete Jørgensen, Kim Dalhoff, Tine Brink Henriksen, Sissel Sundell Haslund-Krog, N.M. Debes
Publikováno v:
Haslund-Krog, S S, Jorgensen, I M, Henriksen, T B, Dalhoff, K, Debes, N M, van den Anker, J & Holst, H 2021, ' Challenges in conducting paediatric trials with off-patent drugs ', Contemporary Clinical Trials Communications, vol. 23, 100783 . https://doi.org/10.1016/j.conctc.2021.100783
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100783-(2021)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100783-(2021)
Introduction For more than two decades several initiatives have emerged to increase recruitment of paediatric patients in drug trials. While trials of newly approved drugs have successfully included paediatric patients in their drug development plan,
Autor:
Jean-Paul Langhendries, Françoise Smets, Karel Allegaert, Francis Veyckemans, J. N. van den Anker
Publikováno v:
Medical Hypotheses, 87, 90-96. Churchill Livingstone
There has been an exponential increase in the frequency of immune deviations in young children. Consequently, research investigating environmental causes for this increase has become a Public Health priority. We have summarized the experimental obser
Autor:
Samira Samiee-Zafarghandy, Christoph P. Hornik, J N van den Anker, Reese H. Clark, M M Laughon, P B Smith
Publikováno v:
Journal of perinatology : official journal of the California Perinatal Association
Journal of Perinatology, 36(2), 137-140. Nature Publishing Group
Journal of Perinatology, 36(2), 137-140. Nature Publishing Group
Objective To examine the effect of sildenafil therapy on development of severe retinopathy of prematurity (ROP) requiring surgical intervention in premature infants. Study Design We identified premature infants who were discharged from Pediatrix Medi
Autor:
J. N. van den Anker, Karel Allegaert
Publikováno v:
Clinical Pharmacology & Therapeutics, 98(3), 288-297. Wiley-Blackwell
Knowledge about the safe and effective use of medicines in neonates has increased substantially but has resulted in few label changes. Drugs developed for use in adults are reshaped and tailored to specific neonatal indications. However, the use of d
Autor:
Gina A. Simone, Andrew Lewandowski, Katherine Y. Berezny, Amy Delinsky, Barrie Harper, Ian M. Paul, T. Bratton, Zhaoxia Ren, Edmund V. Capparelli, B. Poindexter, Andrew M. Atz, Kanecia O. Zimmerman, Kelly C. Wade, J. Sullivan, Thomas J. Walsh, Chiara Melloni, Alice Pagan, T. M. O'Shea, H. Al Nasiri, Daniel Gonzalez, A. Lewandowski, K. Tsilou, David A. Siegel, Gregory L. Kearns, Daniel K. Benjamin, Brenda B. Poindexter, L. Smiley, A. Muelenaer, P B Smith, L. Fern, Michael Cohen-Wolkowiez, Paula Delmore, Janice E. Sullivan, Ravinder Anand, J. N. van den Anker, Donna Cannonier, Anne Zajicek, Ram Yogev, Perdita Taylor-Zapata, R. Yogev, M M Laughon, Kenneth C. Lewis, Susan R. Mendley, B. Harper
Publikováno v:
Bioanalysis. 7:1137-1149
Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is an antimicrobial drug combination commonly prescribed in children and adults. The study objectives were to validate and apply an HPLC–MS/MS method to quantify TMP-SMX in dried plasma spots (DPS
Publikováno v:
BioMed Research International, Vol 2014 (2014)
BioMed Research International
BioMed Research International
Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has been designated as a top priority by the American Society of Nephrology. Increasing knowledge in the science of biology and medicine is leading to the
Autor:
P B Smith, Barry T. Bloom, Edmund V. Capparelli, Mario R. Sampson, Daniel K. Benjamin, Michael Cohen-Wolkowiez, J. N. van den Anker, Antonio Arrieta, G. L. Kearns
Publikováno v:
Journal of Neonatal-Perinatal Medicine. 7:223-228
Fatty acid-binding proteins are small (14-15 kD) proteins that transport fatty acids in enterocytes. Human intestinal fatty acid-binding protein (I-FABP) is found in mature enterocytes of the small intestine [1]. This protein is rapidly released in b
Autor:
T van Donge, Marc Pfister, Gilbert Koch, J. N. van den Anker, Majid Kalani, Samira Samiee-Zafarghandy, Arash Bordbar
Publikováno v:
Archives of Disease in Childhood. 104:e3.1-e3
AimsA dramatic increase in newborn infants with neonatal abstinence syndrome has been observed and these neonates are frequently treated with complex methadone dosing schemes to control their withdrawal symptoms. Despite its abundant use, hardly any